T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Beam Global
BEEM
$25.5M
| $145K | ﹤0.01% |
19,600
+7,700
| +65% | +$72K |
|
2577
Ranpak Holdings
PACK
$474M
| $145K | ﹤0.01% |
26,581
+1,162
| +5% | +$6.37K |
|
2578
Select Water Solutions
WTTR
$2.71B
| $144K | ﹤0.01% |
18,049
+786
| +5% | +$6.46K |
|
2579
EVgo
EVGO
$506M
| $143K | ﹤0.01% |
42,162
+15,477
| +58% | +$63.7K |
|
2580
Organogenesis Holdings
ORGO
$229M
| $143K | ﹤0.01% |
44,671
+785
| +2% | +$2.49K |
|
|
BRY
2581
DELISTED
Berry Corp
BRY
| $142K | ﹤0.01% |
17,272
+2,284
| +15% | +$18.3K |
|
2582
Veritone
VERI
$137M
| $140K | ﹤0.01% |
54,132
+11,514
| +27% | +$38.2K |
|
2583
Phathom Pharmaceuticals
PHAT
$732M
| $139K | ﹤0.01% |
13,394
-38
| -0.3% | -$521 |
|
2584
SIGA Technologies
SIGA
$207M
| $139K | ﹤0.01% |
26,342
+947
| +4% | +$4.67K |
|
|
GRTS
2585
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $139K | ﹤0.01% |
80,535
+15,800
| +24% | +$28.1K |
|
|
DSKE
2586
DELISTED
Daseke, Inc. Common Stock
DSKE
| $139K | ﹤0.01% |
26,949
+848
| +3% | +$5.12K |
|
2587
Treace Medical Concepts
TMCI
$302M
| $138K | ﹤0.01% |
10,480
+1,323
| +14% | +$24.2K |
|
2588
Rimini Street
RMNI
$443M
| $137K | ﹤0.01% |
62,070
+18,635
| +43% | +$56.6K |
|
2589
KRONOS Worldwide
KRO
$974M
| $136K | ﹤0.01% |
17,488
+613
| +4% | +$5.33K |
|
2590
TAL Education Group
TAL
$6.39B
| $136K | ﹤0.01% |
14,900
| – | – |
|
2591
Driven Brands
DRVN
$2.09B
| $134K | ﹤0.01% |
10,606
+1,100
| +12% | +$20.1K |
|
2592
1-800-Flowers.com
FLWS
$260M
| $134K | ﹤0.01% |
19,042
+511
| +3% | +$3.84K |
|
2593
LifeVantage
LFVN
$81.2M
| $134K | ﹤0.01% |
20,700
-5,200
| -20% | -$29.1K |
|
2594
Smith & Wesson
SWBI
$637M
| $134K | ﹤0.01% |
+10,307
| New | +$129K |
|
2595
ARKO Corp
ARKO
$506M
| $132K | ﹤0.01% |
18,341
+1,176
| +7% | +$9.2K |
|
2596
GrowGeneration
GRWG
$109M
| $132K | ﹤0.01% |
45,162
+3,226
| +8% | +$10.6K |
|
2597
Senseonics Holdings Inc
SENS
$412M
| $132K | ﹤0.01% |
10,895
| – | – |
|
2598
Alto Ingredients
ALTO
$326M
| $131K | ﹤0.01% |
29,600
-8,100
| -21% | -$31.3K |
|
2599
Cullinan Oncology
CGEM
$1.28B
| $131K | ﹤0.01% |
14,402
| – | – |
|
2600
Enanta Pharmaceuticals
ENTA
$404M
| $131K | ﹤0.01% |
+11,678
| New | +$188K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.